At the first meeting of the FDA device center's Patient Engagement Advisory Committee meeting, patients and advocacy groups ticked off a list of perceived barriers to more patient engagement in medtech product clinical trials, including patients lacking knowledge on availability of trials, burdens of getting to the trial site, losing work time, and being kept in the dark about trial outcomes while taking part.
The goal of the first meeting of the PEAC, held Oct. 11-12, was to examine how sponsors and FDA can...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?